BrainEver jobs and careers
Saint-antoine, France
About BrainEver
BrainEver’s innovative therapeutic strategy is a translation of the work by Alain Prochiantz and colleagues on brain development and physiology. They demonstrated that homeoproteins, first identified as early developmental regulators, are also active throughout life and control several neuronal functions, including metabolism and epigeneticstability.BrainEver makes the hypothesis that, in patients, homeoprotein administration could durably modify the physiological resistance of surviving neurons while increasing their activity, thus leading to the improvement of clinical symptoms.Different homeoproteins that could be important in different neurodegenerative pathologies are being explored, the most advanced being Engrailed 1 (BREN01) for the treatment of Parkinson Disease and Amyotrophic Lateral Sclerosis (ALS).Beside Engrailed 1 in Parkinson Disease and ALS, BrainEver is currently generating a pipeline of 4 drug candidates targeting other neurodegenerative disease like Huntington Disease and Optic Neuropathies.
- Employees
- 11 to 50
- Headquarters
- Saint-antoine
Leadership
The top of BrainEver's org chart, with how many people report into each leader.
Bernard Gilly
CEO
8 reports
Alain Prochiantz
Co-founder & Chief Scientific Officer
2 reports
Anne Bousseau
Chief Medical Officer
1 report
Catherine Pletan
Acting Chief Operating Officer / Head of Operations
Hubert Mechain
CTO - Chief Technical Officer
Claire Friedel
Business Development
Jobs at BrainEver
No open positions right now. Explore more companies on TheJobsMap.